2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Ovarian Cancer: Do TKI Cediranib and Olaparib Have Potential for Synergistic Activity in Recurrent Platinum Sensitive Ovarian Cancer?

60 views
July 29, 2020
Comments 0
Login to view comments. Click here to Login